Oil giant, Oando Plc has appointed Dr Ainojie Alex Irune as its new Executive Director. Irune’s appointment was disclosed in a notification to the Nigerian Stock Exchange (NSE) and the investing public at large.
The company disclosed that Irune’s appointment would take effect from Friday, August 9, 2019.
What you should know about Irune: Dr Ainojie Alex Irune is the Chief Operating Officer (COO) of Oando Energy Resources (OER), the upstream subsidiary of Oando Plc.
[READ MORE: Why SEC ordered Oando’s Wale Tinubu to resign]
A proponent of transformational leadership, Irune joined the company in 2011 and OER’s management team in 2018. As the COO, he successfully redefined OER’s business model, creating a clearer vision and alignment of focus to achieving the company’s objectives.
To date, his actions have positively impacted the business, specifically in the areas of consolidation of existing assets and operations, improved partner relations, a 21% reduction in company debt profile, a 99% reduction in Reserve Based Lending, increased daily crude oil production by 10% to 16,967 and 2P Reserves position by 2%. Irune also secured over $1.5 billion in international financing.
Prior to assuming his current role, he was the Group Chief Strategy & Corporate Services Officer at Oando Plc from 2016 to 2018. He also served as the Head of Corporate Communications of the company from 2013 to 2016, where he oversaw all internal and external brand-building efforts across the Company’s business entities. He spearheaded the global communications strategy following Oando’s successful $1.5 billion acquisition of ConocoPhillips Nigeria’s upstream assets.
Before joining Oando Plc in 2011, Irune worked in the United Kingdom as an In-Vehicle Systems Researcher and Designer with global leading car manufacturers (Honda, Nissan and Jaguar Land Rover) and the University of Nottingham.
He graduated from the University of Nottingham with a B.Sc. in Computer Science in 2002 and attained his PhD in Computer Science from the same university in 2009.
Meanwhile, the company also disclosed the resignation of Mobolaji Osunsanya, a Non-Executive Director of the company. Ogunsanya, according to Oando Plc, resigned from the Board with effect from Friday, August 9, 2019.
Until his resignation, Ogunsanya was a member of the Audit Committee, Strategy and Finance Committee and the Risk, Environmental, Health, Safety, Security and Quality Committee.
Covid-19: WHO approves China’s Sinopharm vaccine
WHO has announced the approval of China’s Sinopharm vaccine for Covid-19 vaccination.
The World Health Organization (WHO) has announced the approval of China’s Sinopharm vaccine for Covid-19 vaccination. The vaccine is reported to have 79% efficacy against covid.
This was disclosed today in a report by Reuters. The vaccine would also be the second Chinese-made vaccine after Sinovac vaccine and would be the first developed outside Europe and North America to receive WHO accreditation.
“This expands the list of COVID-19 vaccines that COVAX can buy, and gives countries confidence to expedite their own regulatory approval, and to import and administer a vaccine,” WHO Director-General, Tedros Adhanom Ghebreyesus said.
The WHO added that the easy storage requirements make it highly suitable for low-resource settings.
“Its easy storage requirements make it highly suitable for low-resource settings,” a WHO statement said while also disclosing that the vaccine has been approved for people above the age of 18 to receive two shots.
“On the basis of all available evidence, WHO recommends the vaccine for adults 18 years and older, in a two-dose schedule with a spacing of three to four weeks,” the statement added.
The vaccine was created by Beijing Biological Products Institute, a subsidiary of Sinopharm subsidiary China National Biotec Group, with an efficacy of 79% for all age groups.
The WHO however, admitted that few older adults (over 60 years) were enrolled in clinical trials, so efficacy could not be estimated in this age group.
In case you missed it
The quest for vaccine efficiency got a major boost earlier this week as Nairametrics reported that the United States government announced that it supports the waiver of Intellectual Property Protections on Covid-19 vaccine development, in a bid to boost the fight against the pandemic, and says it will participate in the Okonjo-Iweala-led WTO negotiation to make it happen.
“Mama Taraba”, Former minister and senator, Aisha Al-Hassan is dead
Ex-Women Affairs minister, Aisha Jummai Al-Hassan, popularly known as Mama Taraba is dead
A former Minister for Women Affairs and ex-Governorship Candidate in Taraba State, Aisha Jummai Al-Hassan, popularly known as Mama Taraba is dead.
According to media reports she died in a hospital on Friday in Cairo, Egypt at the age of 61.
Al-Hassan, who was a former senator of the Federal Republic of Nigeria from Taraba North Senatorial District, was the All Progressive Congress (APC) Governorship Candidate for Taraba in the 2015 general elections.
She later contested for the same seat on the platform of the United Democratic Party in the 2019 general elections after resigning from APC and as a minister in the administration of President Muhammadu Buhari on July 27, 2018.
The former senator was born on the 16th of September, 1959 in Jalingo, Taraba State, to Alhaji Abubakar Ibrahim, Sarkin Ayukan Muri.
Aisha Jummai Al-Hassan attended Muhammed Nya Primary School, Jalingo and LEA Primary School, Tudun Wada, Kaduna before proceeding to Saint Faith College (now GGSS) Kawo Kaduna where she studied between January 1973 and June 1977.
Nairametrics | Company Earnings
Access our Live Feed portal for the latest company earnings as they drop.
- Okomu Oil proposes dividend worth N6.7 billion for shareholders.
- Ardova Plc confirms appointment of Oladeinde Nelson-Cole as secretary.
- Cadbury Nigeria Plc set to hold 56th Annual General Meeting (AGM) on June 16.
- FCMB Group Plc appoints Muibat Ijaiya as Director.
- Afromedia Plc reports a loss after tax of N27.3 million in Q1 2021.